Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Placebo-controlled Phase II Cross-over Study on the Influence of Fampridine on Working Memory in Individuals With Post COVID-19 Condition With Subjective Cognitive Impairment

NCT05274477 is registered in ClinicalTrials.gov with Prof. Dominique de Quervain, MD as lead sponsor.

NCT NCT05274477
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05274477 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Placebo-controlled Phase II Cross-over Study on the Influence of Fampridine on Working Memory in Individuals With Post COVID-19 Condition With Subjective Cognitive Impairment
Lead sponsor
Prof. Dominique de Quervain, MD
Phase
Not applicable
Overall status
Terminated
Start date
June 28, 2022
Completion date
June 30, 2024
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post-covid-19, working memory